FDA continues investigation into growing number of dogs with heart disease and their diet![](data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%200%200'%3E%3C/svg%3E)
The Food & Drug Administration (FDA) is again warning and sharing updated information about a connection to certain pet foods and dogs developing canine dilated cardiomyopathy.
Otherwise known as DCM, the heart disease has been reported in dogs eating pet foods containing peas, lentils (whole, flour, protein, etc.), other legume seeds, or potatoes listed as the main ingredients. These are usually the first ingredients listed on the packaging.
The FDA says since January 1, 2014-November 30, 2018, there have been 300 reports of DCM following a July 2018 public notification of the potential connection. Whilce DCM can affect large dog breeds due to genetics, the reports include a range of dog breeds.
In 90% of cases reported, dogs reportedly were eating a grain-free diet. 10% were listed as eating diets with grains.
Products fed to the dogs were commercially sold kibble, canned foods, raw foods, and home-cooked diets.
The FDA has not determined a specific recommendation on diet changes for dogs not showing DCM symptoms but is encouraging pet owners to get with their veterinarians to talk about dietary advice.
The FDA is continuing it’s investigation into any correlations between dogs diagnosed with DCM and their diets.
In 90% of cases reported, dogs reportedly were eating a grain-free diet. 10% were listed as eating diets with grains.
Products fed to the dogs were commercially sold kibble, canned foods, raw foods, and home-cooked diets.
The FDA has not determined a specific recommendation on diet changes for dogs not showing DCM symptoms but is encouraging pet owners to get with their veterinarians to talk about dietary advice.
The FDA is continuing it’s investigation into any correlations between dogs diagnosed with DCM and their diets.
The latest articles
CULT Food starts cultivated pet food regulatory race in the US
A subsidiary of the Canadian cell-based firm is to file a feeding trial to seek approval to sell the product in the country.
Purina witnessing a deceleration, admits Nestlé’s CFO
The multinational’s pet portfolio increased sales in the first half of 2024. GlobalPETS dives into the latest earnings.
American biotech companies receive $36 million in investments
California-based NovoNutrients and Digestiva to scale their footprints in alternative protein.
Weekly newsletter to stay up-to-date
Discover what’s happening in the pet industry. Get the must-read stories and insights in your inbox.